Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Symbole: 002693.SZ
SHZ
5.69
CNYPrix du marché aujourd'hui
-39.5632
Ratio P/E
2.2749
Ratio PEG
2.36B
Cap MRK
- 0.00%
Rendement DIV
Hainan Shuangcheng Pharmaceuticals Co., Ltd. (002693-SZ) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 31.9 | 146 | 77 | |||||||||||||||
balance-sheet.row.short-term-investments | 0 | 28.5 | 133.8 | 55.4 | |||||||||||||||
balance-sheet.row.net-receivables | 0 | 16.4 | 41 | 33.1 | |||||||||||||||
balance-sheet.row.inventory | 0 | 74.3 | 65.4 | 55.2 | |||||||||||||||
balance-sheet.row.other-current-assets | 0 | 0.2 | 0 | 0.1 | |||||||||||||||
balance-sheet.row.total-current-assets | 0 | 135.2 | 252.4 | 165.4 | |||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 457.6 | 471.8 | 504.7 | |||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.intangible-assets | 0 | 171.8 | 164.9 | 156.9 | |||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 171.8 | 164.9 | 156.9 | |||||||||||||||
balance-sheet.row.long-term-investments | 0 | 10 | 8.8 | 17.3 | |||||||||||||||
balance-sheet.row.tax-assets | 0 | 1.5 | 1 | 1 | |||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 27.1 | 12.2 | 9.1 | |||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 668 | 658.6 | 689.1 | |||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-assets | 0 | 803.2 | 911 | 854.6 | |||||||||||||||
balance-sheet.row.account-payables | 0 | 17.1 | 15.5 | 17.2 | |||||||||||||||
balance-sheet.row.short-term-debt | 0 | 10.1 | 205.3 | 0.3 | |||||||||||||||
balance-sheet.row.tax-payables | 0 | 3.7 | 12.8 | 7.2 | |||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 135 | 0 | 167 | |||||||||||||||
Deferred Revenue Non Current | 0 | 8 | 7.6 | 8.9 | |||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||
balance-sheet.row.other-current-liab | 0 | 2 | 73.6 | 1.8 | |||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 145.7 | 10.7 | 179.4 | |||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-liab | 0 | 285.6 | 330.1 | 287.8 | |||||||||||||||
balance-sheet.row.preferred-stock | 0 | 34.4 | 0 | 0 | |||||||||||||||
balance-sheet.row.common-stock | 0 | 416.7 | 414.7 | 412 | |||||||||||||||
balance-sheet.row.retained-earnings | 0 | -347 | -296.2 | -305.2 | |||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -0.4 | 87.2 | 82.2 | |||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 367.6 | 307.9 | 292.9 | |||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 471.5 | 513.5 | 481.8 | |||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 803.2 | 911 | 854.6 | |||||||||||||||
balance-sheet.row.minority-interest | 0 | 46.2 | 67.4 | 84.9 | |||||||||||||||
balance-sheet.row.total-equity | 0 | 517.6 | 580.9 | 566.8 | |||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||
Total Investments | 0 | 10 | 133.8 | 55.4 | |||||||||||||||
balance-sheet.row.total-debt | 0 | 145.1 | 205.3 | 167.3 | |||||||||||||||
balance-sheet.row.net-debt | 0 | 141.7 | 193.1 | 145.6 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -8.5 | -40.8 | -79.9 | ||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 57.5 | 54.3 | 57.1 | ||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -0.4 | 0.4 | 1.2 | ||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 6.9 | 7.2 | -1.2 | ||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -4.5 | 14.9 | -12.2 | ||||||||||||||
cash-flows.row.account-receivables | 0 | -13.8 | 5.4 | 39.8 | ||||||||||||||
cash-flows.row.inventory | 0 | -9.9 | -4.8 | -4.3 | ||||||||||||||
cash-flows.row.account-payables | 0 | 19.6 | 13.8 | -48.9 | ||||||||||||||
cash-flows.row.other-working-capital | 0 | -0.4 | 0.4 | 1.2 | ||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -25.8 | -12.5 | 24.5 | ||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -33 | -31.6 | -51.6 | ||||||||||||||
cash-flows.row.acquisitions-net | 0 | 27 | 21.7 | 53.6 | ||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -471 | -256.2 | -637.2 | ||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 391.9 | 299.2 | 615.3 | ||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | -51.6 | ||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -85.1 | 33 | -71.5 | ||||||||||||||
cash-flows.row.debt-repayment | 0 | -12 | -55.3 | -1.8 | ||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.dividends-paid | 0 | -11.1 | -9.1 | -9.8 | ||||||||||||||
cash-flows.row.other-financing-activites | 0 | 68.1 | 23.8 | 57 | ||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 44.9 | -40.6 | 45.4 | ||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0.1 | -0.1 | -0.3 | ||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -14.8 | 15.8 | -36.9 | ||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 6.8 | 21.6 | 5.8 | ||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 21.6 | 5.8 | 42.7 | ||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 25.2 | 23.6 | -10.5 | ||||||||||||||
cash-flows.row.capital-expenditure | 0 | -33 | -31.6 | -51.6 | ||||||||||||||
cash-flows.row.free-cash-flow | 0 | -7.8 | -8.1 | -62.1 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 235.9 | 274.8 | 320.3 | |||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 74.9 | 88.3 | 81.4 | |||||||||||||||
income-statement-row.row.gross-profit | 0 | 161.1 | 186.5 | 238.9 | |||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||
income-statement-row.row.other-expenses | 0 | 0.2 | 63.2 | 69 | |||||||||||||||
income-statement-row.row.operating-expenses | 0 | 183.4 | 215.8 | 282.7 | |||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 258.3 | 304.1 | 364.1 | |||||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 0.1 | 0.1 | |||||||||||||||
income-statement-row.row.interest-expense | 0 | 9.6 | 11.2 | 9 | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -50.6 | 15.6 | 2 | |||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0.2 | 63.2 | 69 | |||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -50.6 | 15.6 | 2 | |||||||||||||||
income-statement-row.row.interest-expense | 0 | 9.6 | 11.2 | 9 | |||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 52.7 | 57.5 | 54.3 | |||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||
income-statement-row.row.operating-income | 0 | -73.2 | -24.5 | -42.3 | |||||||||||||||
income-statement-row.row.income-before-tax | 0 | -73 | -8.9 | -40.4 | |||||||||||||||
income-statement-row.row.income-tax-expense | 0 | -1 | -0.4 | 0.4 | |||||||||||||||
income-statement-row.row.net-income | 0 | -50.7 | -8.5 | -40.8 |
Questions fréquemment posées
Quel est le total de Hainan Shuangcheng Pharmaceuticals Co., Ltd. (002693.SZ) de l'actif total?
Hainan Shuangcheng Pharmaceuticals Co., Ltd. (002693.SZ) Le total des actifs est 803248121.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est N/A.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est 0.654.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est -0.103.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est -0.324.
Quel est le revenu total de l'entreprise?
Le revenu total est -0.443.
Qu'est-ce que Hainan Shuangcheng Pharmaceuticals Co., Ltd. (002693.SZ) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est -50741578.370.
Quel est l'endettement total de l'entreprise?
La dette totale est 145050750.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 183423820.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 0.000.